Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859336 · ClinicalTrials.gov registry record · NA
High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD
A NA study, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03859336 is a NA study that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 10 participants.
The verdict
NCT03859336, a NA study, has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the feasibility of cervical TEN stimulation (TENS) delivered to the back of the neck to decrease anxiety and sleep issues in young adults with Autism Spectrum Disorder (ASD). The specific aim is to determine the effect of TENS, delivered over 3 daily sessions, on anxiety and sleep quality in young adults with ASD, as compared to sham and baseline. The investigator will enroll up to 10 young adults, aged 10 to 25 years of age with confirmed ASD and measureable anxiety and sleep disturbance symptoms, and participation will last 3 weeks.
Interventions
- DEVICE Transdermal Neuromodulation Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2021-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859336
The ClinicalTrials.gov registry entry for NCT03859336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdermal Neuromodulation Stimulation is the first listed.
NCT03859336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859336 about?
NCT03859336 is a clinical study titled "High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD". The objective of this study is to investigate the feasibility of cervical TEN stimulation (TENS) delivered to the back of the neck to decrease anxiety and sleep issues in young adults with Autism Spectrum Disorder (ASD). The specific aim is to determine the effect of TENS, delivered over 3 daily ses...
What is the current status of trial NCT03859336?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-05-21. Estimated completion is 2021-10-06.
What interventions are being tested in trial NCT03859336?
The interventions under investigation include: Transdermal Neuromodulation Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03859336?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.